Patent · US Expired

Use of ADAM 12 for diagnosis and therapy of preeclampsia

US7842464B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM · DE

Inventors

Sabine Gack · Plankstadt, DE
Marina Schorpp-Kistner · Durmersheim, DE
Peter Angel · Dossenheim, DE
Gunnar Wrobel · Heidelberg, DE
Peter Lichter · Heidelberg, DE
Alexander Marme · Heidelberg, DE
Susanne Stumm · Leimen, DE

Key dates

Filing date	Oct 15, 2004
Grant date	Nov 30, 2010
Priority date	—
Expiry date	Mar 15, 2026

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/368
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to the significant role of ADAM 12, ADAM 12-L, and ADAM 12-S in preeclampsia and related disorders. The invention further relates to the use of said genes and gene products, ligands binding to those, and modulators of activity of the gene products in diagnosis and treatment of preeclampsia and related syndromes. The invention also relates to the use of further genes and combinations thereof in diagnosis of preeclampsia and related syndromes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.